Your browser doesn't support javascript.
loading
Transcriptional profiles define drug refractory disease in myeloma.
Zhu, Yuan Xiao; Bruins, Laura A; Chen, Xianfeng; Shi, Chang-Xin; Bonolo De Campos, Cecilia; Meurice, Nathalie; Wang, Xuewei; Ahmann, Greg J; Ramsower, Colleen A; Braggio, Esteban; Rimsza, Lisa M; Stewart, A Keith.
Affiliation
  • Zhu YX; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Bruins LA; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Chen X; Division of Biomedical Statistics and Informatics, Department of Health Science Research Mayo Clinic Rochester Minnesota USA.
  • Shi CX; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Bonolo De Campos C; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Meurice N; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Wang X; Division of Biomedical Statistics and Informatics, Department of Health Science Research Mayo Clinic Rochester Minnesota USA.
  • Ahmann GJ; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Ramsower CA; Department of Laboratory Medicine and Pathology Mayo Clinic Phoenix Arizona USA.
  • Braggio E; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Rimsza LM; Department of Laboratory Medicine and Pathology Mayo Clinic Phoenix Arizona USA.
  • Stewart AK; Division of Medical Oncology and Hematology Princess Margaret Cancer Centre Toronto Ontario Canada.
EJHaem ; 3(3): 804-814, 2022 Aug.
Article in En | MEDLINE | ID: mdl-36051067

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: EJHaem Year: 2022 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: EJHaem Year: 2022 Document type: Article Country of publication: Estados Unidos